Lanoconazole  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 10mg 25mg in glass bottle
产品描述:基本信息 产品编号:L10285 产品名称:Lanoconazole CAS: 101530-10-3   储存条件 粉末 -20℃ 四年     分子式: C14H10ClN3S2 溶于液体 -80℃ 六个月 分子量 319.83 -20℃ 一个月 化学名:  (2E)-2-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile   Solubility (25°C)   体外 DMSO 100mg/mL (312.67mM Need ultrasonic) Ethanol   Water   体内 现配现用   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 3.1267mL 15.6333mL 31.2666mL 5mM 0.6253mL 3.1267mL 6.2533mL 10mM 0.3127mL 1.5633mL 3.1267mL   生物活性 产品描述 一种强效口服咪唑类抗真菌试剂,具有广谱的体内外抗真菌活性。 靶点/IC50 antifungal IC50:   体内研究 Lanoconazole (treatment for ear; 0.3%-3%; 6 days) dose‐dependently suppressesTPA-induced irritant dermatitis,suppresses the production of neutrophil chemotactic factors such as keratinocyte‐derived chemokine and macrophage inflammatory protein‐2, and inhibited neutrophil infiltration to the inflammation site.Lanoconazole (oral administration; 3, 10 or 30mg/kg; once a day; 3 weeks) significantly inhibits C. neoformans compared with the saline control in normal mice. In addtion, it significantly reduces the growth of C. neoformans in the lungs and brains of MAIDS mice Animal Model: BALB/c mice Dosage: 0.3%-3% dosage Administration: Treatment for ear Result: Exhibited an inhibition effect of LCZ on ear swelling induced by topical application of TPA in mice.   Animal Model: Four week old C57BL/6 mice infected intraperitoneally with LP-BM5 murine leukaemia virus Dosage: 3, 10 or 30mg/kg Administration: Oral adminstration Result: Inhibited C. neoformans  growth in both normal and C. neoformans -induced encephalitis MAIDS mice.
保存条件:-20℃